<DOC>
	<DOCNO>NCT01805466</DOCNO>
	<brief_summary>The primary purpose study ass effect use EVADO respect conventional cardio-pulmonary bypass ( CBP ) system surgical morbidity mortality . As secondary aim study want conduct appropriate laboratory investigation order detect major biological mechanism potentially responsible beneficial effect EVADO system coagulation cascade inflammatory activation .</brief_summary>
	<brief_title>Effects Organ Damage Surgical Outcome New Cardiopulmonary Pass System ( EVADO )</brief_title>
	<detailed_description>The present study design prospective , multicentre , randomize , open label , control , 2-arm parallel group , superiority trial . Participating centre select base previous experience use EVADO system . Patients elect open heart surgery variety cardiac condition related coronary , valvular aortic disease combination participate center screen . This study secondary aim want confirm result earlier investigation multicentre trial conduct large population patient undergoing wide spectrum open heart cardiac operation either assess number cost-efficacy-efficiency indicator .</detailed_description>
	<criteria>patient elect undergo open heart surgery variety cardiac condition related coronary , valvular aortic disease combination fulfil follow additional criterion : Written inform consent Age 1885 year Severe renal liver failure Uncompensated diabetes Autoimmune disease require immunosuppressant therapy Coagulation disorder Emergent redo surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Extracorporeal Vacuum Assisted Device Optimised ( EVADO )</keyword>
</DOC>